1. Home
  2. CTMX vs USEG Comparison

CTMX vs USEG Comparison

Compare CTMX & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • USEG
  • Stock Information
  • Founded
  • CTMX 2008
  • USEG 1966
  • Country
  • CTMX United States
  • USEG United States
  • Employees
  • CTMX N/A
  • USEG N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • USEG Oil & Gas Production
  • Sector
  • CTMX Health Care
  • USEG Energy
  • Exchange
  • CTMX Nasdaq
  • USEG Nasdaq
  • Market Cap
  • CTMX 444.3M
  • USEG 42.2M
  • IPO Year
  • CTMX 2015
  • USEG N/A
  • Fundamental
  • Price
  • CTMX $2.48
  • USEG $1.37
  • Analyst Decision
  • CTMX Strong Buy
  • USEG Strong Buy
  • Analyst Count
  • CTMX 2
  • USEG 1
  • Target Price
  • CTMX $5.00
  • USEG $3.50
  • AVG Volume (30 Days)
  • CTMX 2.7M
  • USEG 9.4M
  • Earning Date
  • CTMX 08-07-2025
  • USEG 08-06-2025
  • Dividend Yield
  • CTMX N/A
  • USEG N/A
  • EPS Growth
  • CTMX 128.27
  • USEG N/A
  • EPS
  • CTMX 0.49
  • USEG N/A
  • Revenue
  • CTMX $147,557,000.00
  • USEG $16,340,000.00
  • Revenue This Year
  • CTMX N/A
  • USEG $23.82
  • Revenue Next Year
  • CTMX N/A
  • USEG N/A
  • P/E Ratio
  • CTMX $5.11
  • USEG N/A
  • Revenue Growth
  • CTMX 23.81
  • USEG N/A
  • 52 Week Low
  • CTMX $0.40
  • USEG $0.81
  • 52 Week High
  • CTMX $3.10
  • USEG $6.40
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 56.59
  • USEG 46.23
  • Support Level
  • CTMX $2.15
  • USEG $1.34
  • Resistance Level
  • CTMX $2.44
  • USEG $1.69
  • Average True Range (ATR)
  • CTMX 0.24
  • USEG 0.30
  • MACD
  • CTMX -0.05
  • USEG -0.06
  • Stochastic Oscillator
  • CTMX 39.71
  • USEG 2.82

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

Share on Social Networks: